| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/09/2001 | CA2192079C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen |
| 01/08/2001 | CA2274880A1 Icam-6 materials and methods |
| 01/04/2001 | WO2001001150A2 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | WO2001000879A1 Novel kinases and uses thereof |
| 01/04/2001 | WO2001000874A2 Cancer associated antigens and uses therefor |
| 01/04/2001 | WO2001000851A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | WO2001000849A1 Tankyrase2 materials and methods |
| 01/04/2001 | WO2001000846A2 Linoleate isomerase |
| 01/04/2001 | WO2001000839A1 Tetanus toxin polypeptides |
| 01/04/2001 | WO2001000837A1 Basb111 polypeptide and polynucleotide from moraxella catharrhalis |
| 01/04/2001 | WO2001000831A1 Helical polypeptide zalpha29 |
| 01/04/2001 | WO2001000829A2 Human endogenous retrovirus in breast cancer |
| 01/04/2001 | WO2001000828A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | WO2001000824A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 01/04/2001 | WO2001000822A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 01/04/2001 | WO2001000812A2 22012, a novel human carboxypeptidase |
| 01/04/2001 | WO2001000811A2 17867, a novel human aminopeptidase |
| 01/04/2001 | WO2001000810A1 Glycoprotein vi and uses thereof |
| 01/04/2001 | WO2001000799A1 Novel protein and dna thereof |
| 01/04/2001 | WO2001000679A2 Methods for inducing t cell non-responsiveness to a tissue or organ graft |
| 01/04/2001 | WO2001000678A1 Human monoclonal antibodies to hiv-1 envelope glycoprotein gp120 |
| 01/04/2001 | WO2001000648A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | WO2001000245A2 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 01/04/2001 | WO2001000238A1 TREATING PROSTATE CANCER WITH ANTI-ErbB2 ANTIBODIES |
| 01/04/2001 | WO2001000237A1 Synthetic peptide immunogens and antibodies thereto |
| 01/04/2001 | WO2001000235A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia |
| 01/04/2001 | WO2000060082A3 Vesicle associated proteins |
| 01/04/2001 | WO2000056405A3 Human tumor necrosis factor receptor-like 2 |
| 01/04/2001 | WO2000038715A3 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 01/04/2001 | WO2000029438A9 Egf-like nucleic acids and polypeptides and uses thereof |
| 01/04/2001 | WO2000026251A9 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX |
| 01/04/2001 | WO2000000161A3 Methods for identification of tef-3 interacting factors |
| 01/04/2001 | CA2727172A1 Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 01/04/2001 | CA2380873A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/04/2001 | CA2377580A1 Helical polypeptide zalpha29 |
| 01/04/2001 | CA2377531A1 Basb111 polypeptide and polynucleotide from moraxella catarrhalis |
| 01/04/2001 | CA2377484A1 Cyclic amp phosphodiesterase isoforms and methods of use |
| 01/04/2001 | CA2377473A1 Linoleate isomerase |
| 01/04/2001 | CA2376914A1 Prion protein binding proteins and uses thereof |
| 01/04/2001 | CA2372700A1 Diagnostic test for thrombotic or thromboembolic disease |
| 01/04/2001 | CA2372696A1 Novel protein and dna thereof |
| 01/04/2001 | CA2370568A1 Tankyrase2 materials and methods |
| 01/04/2001 | CA2370517A1 Stabilized viral envelope proteins and uses thereof |
| 01/04/2001 | CA2339404A1 Synthetic peptide immunogens and antibodies thereto |
| 01/03/2001 | EP1065271A1 Phagemide for screening antibodies |
| 01/03/2001 | EP1065269A1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
| 01/03/2001 | EP1065214A1 Novel physiologically active peptides and utilization thereof |
| 01/03/2001 | EP1064551A1 Development of human monoclonal antibodies and uses thereof |
| 01/03/2001 | EP1064550A1 AN EQUINE $i(NEOSPORA) ISOLATE AND ITS USES |
| 01/03/2001 | EP1064388A1 Human casb12 polypeptide, a serine protease |
| 01/03/2001 | EP1064382A2 Polypeptides homologous to vegf and bmp1 |
| 01/03/2001 | EP1064381A1 Cardiostatin polypeptides and polynucleotides |
| 01/03/2001 | EP1064380A1 EXPRESSION OF THE $i(INSL4) GENE IN HUMAN EMBRYONIC BONE TISSUES AND APPLICATIONS |
| 01/03/2001 | EP1064379A2 Human nucleic acid sequences from tissue of breast tumors |
| 01/03/2001 | EP1064378A2 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/03/2001 | EP1064377A1 Casb414: antigen overexpressed in several tumours |
| 01/03/2001 | EP1064376A2 GFR$g(a)3 AND ITS USES |
| 01/03/2001 | EP1064375A2 Human calcium-binding proteins |
| 01/03/2001 | EP1064372A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/03/2001 | EP1064371A2 Isolated mammalian membrane protein genes and related reagents |
| 01/03/2001 | EP1064370A2 Protein phosphatase-related molecules |
| 01/03/2001 | EP1064368A1 Suppressors of cytokine signalling |
| 01/03/2001 | EP1064366A1 $i(STAPHYLOCOCCUS AUREUS) GENES AND POLYPEPTIDES |
| 01/03/2001 | EP1064364A1 The cytokine family member 2-21 |
| 01/03/2001 | EP1064360A2 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics |
| 01/03/2001 | EP1064309A2 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of hcv viral antigen in host tissue |
| 01/03/2001 | EP1064308A1 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 01/03/2001 | EP1064307A1 Nk cell activation inducing ligand (nail) dna and polypeptides, and use thereof |
| 01/03/2001 | EP1064306A1 $i(NEPHRIN) GENE AND PROTEIN |
| 01/03/2001 | EP1064303A1 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen |
| 01/03/2001 | EP1064297A1 95 human secreted proteins |
| 01/03/2001 | EP1064295A1 METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING CHROMOSOME-18p RELATED DISORDERS |
| 01/03/2001 | EP1064027A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 01/03/2001 | EP1064026A1 Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 01/03/2001 | EP1064023A1 Products in the treatment of cancer |
| 01/03/2001 | EP1064007A1 nrdG |
| 01/03/2001 | EP1064006A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 01/03/2001 | EP1064005A1 Urokinase plasminogen activator receptor as a target for diagnosis of metastases |
| 01/03/2001 | EP1063997A2 Peripheral-type benzodiazepine receptor: a tool for detection, diagnosis, prognosis, and treatment of cancer |
| 01/03/2001 | EP0816506B1 System for the expression of heterologous antigens as fusion proteins |
| 01/03/2001 | CN1278736A Hmanized antibodies to human gp39, compositions containing and therapeutic use thereof |
| 01/02/2001 | US6169175 Dna sequence encoding a variant m2 polypeptide of influenza a having a deletion of a domain, thus causing a reduction in hydrophobicity and an increase solubility in aqueous buffers |
| 01/02/2001 | US6169167 Antibodies to ligands for HEK4 receptors |
| 01/02/2001 | US6168943 Methods for making modified recombinant vesiculoviruses |
| 01/02/2001 | US6168942 Attenuated forms of bovine viral diarrhea virus |
| 01/02/2001 | US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport |
| 01/02/2001 | US6168926 Screening for modulators of preferential enzyme activity; incubating cells with modulators and detecting expression of reporter molecules, amplification of expression indicates an inhibitor, decreased expression indicates an activator |
| 01/02/2001 | US6168925 Monitoring the binding of an anticoagulant; detection of protein bound antibody, detection of a second bound antibody, monitoring the amount of bound antibody, evaluating amount of time antibody is bound |
| 01/02/2001 | US6168923 Compositions and methods for use of IL-12 as an adjuvant |
| 01/02/2001 | US6168920 Extracellular adhesive proteins |
| 01/02/2001 | US6168791 Antibodies that bind immunomodulators |
| 01/02/2001 | US6168790 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 01/02/2001 | US6168785 Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents |
| 01/02/2001 | US6168783 Antagonists of interleukin-15 |
| 01/02/2001 | CA2035899C Chimeric anti-cea antibody |
| 01/02/2001 | CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof |
| 01/02/2001 | CA2007336C Diagnostic test using chimeric antibodies |
| 12/28/2000 | WO2000079284A1 Cartilage resorption assays |
| 12/28/2000 | WO2000079280A1 Srsv detection kit |